Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshifumi Watanabe is active.

Publication


Featured researches published by Toshifumi Watanabe.


Computers and Biomedical Research | 1981

A practical microcomputer-based mapping system for body surface, precordium, and epicardium☆

Toshifumi Watanabe; Junji Toyama; Hideaki Toyoshima; Hajime Oguri; Miyoshi Ohno; Toshiki Ohta; Mitsuharu Okajima; Yoshihide Naito; Kazuo Yamada

Abstract A practical microcomputer-based mapping system is introduced for three different potential mapping applications: (1) an array of 48 AgAgCl electrodes for epicardial mapping, (2) a system of 64 AgAgCl dry electrode for precordial mapping, and (3) an 87-electrode configuration for general body surface potential mapping. The compact, mobile microcomputer system with multiplexing and sample-and-hold techniques makes it possible to construct high-resolution maps from simultaneously sampled ECG potential data in clinical and experimental conditions. It takes only 20–25 min from the beginning of electrode placement to the completion of potential or isochronic map displays on the graphic terminal. Digital magnetic cassette tapes are used as external storage mediums which permit interchange of stored data on a larger computer.


British Journal of Pharmacology | 1989

Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea‐pig hearts

Haruo Honjo; Toshifumi Watanabe; Kaichiro Kamiya; Itsuo Kodama; Junji Toyama

1 The effects of propafenone on the transmembrane action potential and sarcomere shortening during twitch contraction were investigated in single ventricular myocytes isolated from guinea‐pig hearts. 2 Propafenone at low concentrations (3–5 × 10−7 m) slightly lengthened action potential duration (APD), but shortened it at higher concentrations. The shortening of APD was accompanied by an attenuation of sarcomere shortening during twitch contraction. 3 Propafenone (>10−6 m) caused a concentration‐dependent decrease in the maximum upstroke velocity () of the action potential. In the presence of propafenone (3 × 10−6 m), trains of stimuli led to an exponential decline in A time constant for the recovery of from the use‐dependent block was 4.8 s. 4 In myocytes treated with propafenone (3 × 10−6 m), the of test action potentials preceded by the conditioning clamp pulses to 0mV was progressively decreased by increasing the duration of single clamp pulse or by increasing the number of multiple brief clamp pulses. 5 These findings suggest that propafenone has use‐dependent inhibitory action on the sodium channel by binding to the channel during both activated and inactivated states, and that the unbinding rate is comparable to that of Class‐I antiarrhythmic drugs with intermediate kinetics. Propafenone may also have an inhibitory action on calcium and potassium channels.


Journal of Molecular and Cellular Cardiology | 1989

Fluctuations of membrane potential in isolated single ventricular myocytes of guinea-pig upon resumption of oxidative phosphorylation

Haruo Honjo; Junji Toyama; Itsuo Kodama; Toshio Sato; Toshifumi Watanabe; Kazuo Yamada

Electrical and mechanical activities of guinea-pig single ventricular myocytes were investigated under conditions simulating hypoxia-reoxygenation. The localized movement of sarcomere was recorded simultaneously with membrane potential, and analyzed using microcomputer-based image processing. Exposure to 5 mM CN- caused progressive shortening of action potential duration and attenuation of twitch contraction. The myocytes became inexcitable about 30 to 70 min after the CN- treatment. On removal of CN-, the myocytes exhibited periodic miniature membrane depolarizations from the resting potential level (-95 mV). When depolarizations were smaller than 6 mV in amplitude and longer than 500 ms in duration, they were accompanied by localized sarcomere shortening like a propagating contractile wave (unifocal oscillation). Membrane depolarizations of larger amplitude and shorter duration were associated with a more uniform pattern of localized sarcomere shortening (multifocal oscillation). Trains of electrical stimuli applied during the washing out period caused transient augmentation of potential fluctuation and enhancement of synchronization of sarcomere shortening. These results suggest that non-uniform elevation of intracellular calcium concentration on the resumption of oxidative phosphorylation may initiate oscillatory fluctuations of membrane potential leading to abnormal spontaneous excitation.


IEEE Transactions on Biomedical Engineering | 1988

Microcomputer-based image processing system for measuring sarcomere motion of single cardiac cells

T. Sato; Toshifumi Watanabe; Haruo Honjo; Y. Naito; Itsuo Kodama; Junji Toyama

A microcomputer-based image processing system that was developed to obtain contractile properties of single heart cells is described. Cell images were videotaped while action potentials were recorded and were digitized and processed to measure sarcomere length during cell shortening. This system makes it possible to study action potentials and their associated contractions simultaneously.<<ETX>>


Journal of Medicinal Chemistry | 2002

Novel, non-acylguanidine-type Na(+)/H(+) exchanger inhibitors: synthesis and pharmacology of 5-tetrahydroquinolinylidene aminoguanidine derivatives.

Shoji Fukumoto; Eiko Imamiya; Keiji Kusumoto; Shuji Fujiwara; Toshifumi Watanabe; Mitsuru Shiraishi


Archive | 2001

Preventing/remedies for portal hypertension

Toshifumi Watanabe; Keiji Kusumoto; Mami Ojima


Japanese Circulation Journal-english Edition | 1988

DIVERSE CHARACTERISTICS IN POTENTIAL WAVEFORM OF HIS-PURKINJE SYSTEM : Experimental and Simulation Studies

Junji Toyama; Chiharu Satoh; Toshifumi Watanabe; Itsuo Kodama; Kazuo Yamada


Archive | 2006

Agent for preventing or treating portal hypertension

Toshifumi Watanabe; Keiji Kusumoto; Mami Ojima


Journal of Molecular and Cellular Cardiology | 2001

In vitro and in vivo pharmacology of a non-acylguanidine Na-H exchange inhibitor,T 162559

Keiji Kusumoto; Hideki Igata; Akemi Abe; Shota Ikeda; Ayako Tsuboi; Shuji Fujiwara; Manami Kaneko; Tomohiro Kawamoto; Eikoh Imamiya; Nobuhiro Nishigaki; Hiroyuki Kimura; Shoji Fukumoto; Mitsuru Shiraishi; Toshifumi Watanabe


Archive | 1995

Lipometabolism-improving agent

Mitsuru Shiraishi; Toshifumi Watanabe; 敏文 渡邉; 充 白石

Collaboration


Dive into the Toshifumi Watanabe's collaboration.

Top Co-Authors

Avatar

Mitsuru Shiraishi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keiji Kusumoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mami Ojima

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tsuyoshi Maekawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge